IMRN
Immuron Limited
NASDAQ · Healthcare · Biotechnology · AU
$1.80
+62.16%Margins
Gross margin
64.3%
EBITDA margin
-71.4%
EBIT margin
-71.1%
Net margin
-63.0%
FCF margin
-50.8%
-72.3%
Return on equity
-61.2%
Return on assets
-81.5%
Return on invested capital
0.90x
Asset turnover
-$4.6M
Cash from operations
$0.80
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026